IP Library Assignment 054421/0390
Patent Assignment
Reel/Frame 054421/0390

Corrective Assignment to Correct the U.S. Patent 9,399,023 Is Correctnot U.S. Patent 9,339,023 Previously Recorded on Reel 054358 Frame 0326. Assignor(S) Hereby Confirms the Basilea Pharmaceuticainternational Ltd (Nov. 1, 2020).

Recorded: 2020-11-16 Pages: 7
Assignor
Assignee
GALEPHAR PHARMACEUTICAL RESEARCH, INC.
ROAD 925, KM 6.1, BO. JUNQUITO, HC04 BOX4050, HUMACAO, PUERTO RICO 00792, PUERTO RICO, 00792
Covered Property (1)
Formulation for Retinoid-Containing Soft Gelatin Capsules
Patent: 9,399,023 →
Application: 14/734,249 →
Publication: US 2015/0265539
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 10, 2015
From: DITZINGER, GUNTER; GABRIEL, BERNHARD; SCHMITT-HOFFMANN, ANNE-HORTENSE; WEVELSIEP, LUTZ
To: BASILEA PHARMACEUTICA AG
Reel/Frame 035814/0718 →
Assignment of Assignor's Interest Jun 10, 2015
From: BASILEA PHARMACEUTICA INTERNATIONAL LTD.
To: GLAXO GROUP LIMITED
Reel/Frame 035875/0853 →
Assignment of Assignor's Interest Aug 27, 2017
From: GLAXO GROUP LIMITED
To: BASILEA PHARMACEUTICA INTERNATIONAL LTD.
Reel/Frame 043414/0552 →